Chittorgarh.com Logo
Loading...

Parabolic Drugs IPO Latest News Today

Parabolic Drugs IPO Details

IPO Open Jun 14, 2010
IPO Close Jun 17, 2010
IPO Price ₹75
Face Value ₹10
IPO Size ₹200.00 Cr
Listing At BSE, NSE
Lot Size 80
Open an Instant Account with Zerodha
  1. Hempacco IPO: HPCO Stock is Ready to Roll

    Aug 30, 2022 7:54:00 AM

    The Hempacco IPO enters the stock market with its August 30, 2022 debut. In fact, many investors are keeping a close eye on HPCO stock. So, what is Hempacco and what can investors expect from its ...

    Publish by : Investment U
  2. 3 IPO Stocks to Watch in September

    Sep 4, 2022 3:44:00 PM

    PepGen has another three drug candidates in the discovery and preclinical phases – but the shift to human clinical trials is expensive. To raise the capital for that, the company held its IPO in ...

    Publish by : Yahoo Finance
  3. Anticoagulant drug developer Cardrenal Therapeutics files for $10M IPO

    Sep 23, 2022 2:52:00 AM

    Anticoagulant drug developer Cardrenal Therapeutics (CVKD ... Phase 3 clinical trial for the product in 2023. For more IPO news, check out SA's IPO News page.

    Publish by : Seeking Alpha
  4. Welcure Drugs & IPO

    Sep 22, 2022 4:11:00 PM

    The IPO page of Welcure Drugs & Pharmaceuticals Ltd. captures the details on its Issue Open Date, Issue Close Date, Listing Date, Face Value, Price band, Issue Size, Issue Type, and Listing Date's ...

    Publish by : Indiatimes
  5. Fundrise IPO: Information for Investors

    Sep 22, 2022 5:19:00 PM

    Moreover, Fundrise came up with an innovative way to raise capital through an internet public offering. Through the IPO, existing investors can contribute funds and get equity stakes in the company ...

    Publish by : Investment U
  6. What Is An IPO?

    Sep 22, 2022 8:47:00 PM

    Commissions do not affect our editors' opinions or evaluations. An IPO is an initial public offering. In an IPO, a privately owned company lists its shares on a stock exchange, making them ...

    Publish by : Forbes
  7. Porsche’s blockbuster IPO will copy Ferrari’s and sets it up to compete with Tesla

    Sep 23, 2022 4:34:00 PM

    Its profit margins are lavish. The Porsche IPO should happen in the next couple of weeks, even though the war in Ukraine and the energy crisis it triggered have put investors everywhere on edge.

    Publish by : The Globe and Mail
  8. How the IPO market went from boom to bust

    Sep 24, 2022 2:24:00 PM

    "Investors are really risk averse at this moment, and that's what's really impacting the lack of activity that we're seeing," said Rachel Gerring, IPO leader at EY Americas, in an interview with CNBC.

    Publish by : CNBC
  9. Chobani withdraws IPO plans after yogurt maker filed in November to go public

    Sep 3, 2022 2:30:00 AM

    Chobani joins payroll vendor Justworks, grocer Fresh Market and file-sharing company WeTransfer in canceling its IPO this year. In an emailed statement, Chobani cited current market conditions for ...

    Publish by : CNBC
  10. Digit Insurance’s planned IPO put on hold by Indian watchdog

    Sep 20, 2022 4:55:00 PM

    Digit Insurance, a company backed by Canadian billionaire Prem Watsa’s Fairfax Group, has had a planned initial public offering (IPO) put on hold, a Securities and Exchange Board of India (SEBI ...

    Publish by : The Globe and Mail
  11. IPO Plus - IPO Main Page

    Sep 26, 2022 3:30:00 AM

    4.If the company is listed by way of introduction, or transferred to the Main Board from GEM, opening price on debut will be deemed as the Listing Price. 5.% Chg. on debut: [(Closing price on ...

    Publish by : ???????
  12. Borders drugs firm plans IPO after £4.45m acquisition

    Sep 24, 2022 12:08:00 AM

    A Scottish biotech company is aiming for an IPO after raising £4.45 million to acquire a business in the south of England. Ryboquin has bought Sussex-based Nanogenic Solutions to form a new product ...

    Publish by : dailybusinessgroup

Parabolic Drugs IPO Alerts

1. Parabolic Drugs Limited IPO - Listing  Thursday, July 1, 2010 12:00:00 AM

IPO Listing Detail

Listing Date: Thursday, July 01, 2010
BSE Scrip Code: 533211
NSE Symbol: PARABOLIC
Listing In: 'B' Group of Securities
ISIN: INE618H01016
Issue Price: Rs. 75.00 Per Equity Share
Face Value: Rs. 10.00 Per Equity Share

2. IPO Listing - Parabolic Drugs Limited  Wednesday, June 30, 2010 4:24:04 AM

IPO Listing Detail

Listing Date: Thursday, July 01, 2010
BSE Scrip Code: 533211
NSE Symbol: PARABOLIC
Listing In: 'B' Group of Securities
ISIN: INE618H01016
Issue Price: Rs. 75.00 Per Equity Share
Face Value: Rs. 10.00 Per Equity Share

3. IPO Allotment - Parabolic Drugs Limited  Monday, June 28, 2010 1:03:23 AM

Parabolic Drugs Ltd IPO allotment status is now available online.

Parabolic Drugs IPO was open on Jun 14, 2010 and closed on Jun 17, 2010. IPO was oversubscribed by 1.04 times (0.4000 times in retail).

4. Parabolic Drugs Limited IPO - Allotment  Monday, June 28, 2010 12:00:00 AM

Parabolic Drugs Ltd IPO allotment status is now available online.

Parabolic Drugs IPO was open on Jun 14, 2010 and closed on Jun 17, 2010. IPO was oversubscribed by 1.04 times (0.4000 times in retail).

5. Parabolic Drugs Ltd IPO finally subscribed 1.04 times  Thursday, June 17, 2010 9:40:41 AM

Parabolic Drugs Ltd IPO finally subscribed 1.04 times on its closing day. Parabolic Drugs Ltd IPO was open on Jun 14, 2010 and closed today on Jun 17, 2010 for subscription. Parabolic Drugs Ltd has received bids for 2,77,52,400 shares as against issue size of 2,66,66,667 shares.

Oversubscription detail

Qualified Institutional Buyers (QIBs): 1.48 Times

Non Institutional Investors: 1.20 Times

Retail Individual Investors (RIIs): 0.40 Times

Employee: 0.11 Times

Total: 1.04 Times

6. Parabolic Drugs Limited IPO - Close  Thursday, June 17, 2010 12:00:00 AM

Parabolic Drugs Limited is entering in the capital markets with an initial public offering, IPO of Rs. 200 Crore. The price band for the issue has not been decided yet.

Incorporated in 1996, Parabolic Drugs Limited is in the business of manufacturing Active Pharmaceutical Ingredients (API's) and API intermediates. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients.

The issue opens on Jun 14, 2010, and closes for subscription on Jun 17, 2010. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

7. Parabolic Drugs Limited IPO - Open  Monday, June 14, 2010 12:00:00 AM

Parabolic Drugs Limited is entering in the capital markets with an initial public offering, IPO of Rs. 200 Crore. The price band for the issue has not been decided yet.

Incorporated in 1996, Parabolic Drugs Limited is in the business of manufacturing Active Pharmaceutical Ingredients (API's) and API intermediates. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients.

The issue opens on Jun 14, 2010, and closes for subscription on Jun 17, 2010. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

8. Upcoming IPO - Parabolic Drugs Limited  Tuesday, June 8, 2010 11:36:42 PM

Parabolic Drugs Limited is entering in the capital markets with an initial public offering, IPO of Rs. 200 Crore. The price band for the issue has not been decided yet.

Incorporated in 1996, Parabolic Drugs Limited is in the business of manufacturing Active Pharmaceutical Ingredients (API's) and API intermediates. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients.

The issue opens on Jun 14, 2010, and closes for subscription on Jun 17, 2010. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

Parabolic Drugs IPO News & Events FAQs

The Parabolic Drugs IPO is proposed to open on Jun 14, 2010. The IPO application ends on Jun 17, 2010.

Retail investors can apply in the retail or non-institutional investor category from Jun 14, 2010 to Jun 17, 2010. The Parabolic Drugs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Parabolic Drugs IPO will open for subscription on Jun 14, 2010. The public issue will close on Jun 17, 2010.